4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-067431
Chief Financial Officer sold 42,120 shares at an average $80.48 ($3,389,756)
- Chief Financial Officer acquired 42,120 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Hunter C Chief Financial Officer | 2025-07-09 | Option exercise 10b5-1 | +42,120 | $6.88 | $289,786 | 159,035 | D: show line 1 in the form |
| Smith Hunter C Chief Financial Officer | 2025-07-09 | Sale 10b5-1 | −17,113 | $75.38 | $1,290,050 | 141,922 | D: show line 2 in the form |
| Smith Hunter C Chief Financial Officer | 2025-07-09 | Sale 10b5-1 | −1,607 | $76.17 | $122,406 | 140,315 | D: show line 3 in the form |
| Smith Hunter C Chief Financial Officer | 2025-07-09 | Sale 10b5-1 | −23,400 | $84.50 | $1,977,300 | 116,915 | D: show line 4 in the form |
| Open-market sales · 42,120 sh · avg $80.48 · $3,389,756 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Smith Hunter C Chief Financial Officer | 2025-07-09 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −42,120 | 28,088 | D: show line 5 in the form |
Loading xslF345X05/tm2520691-4_4seq1.xml…